Device Trial Radar · NCT07021014
NightWare and Cardiovascular Health in Women With PTSD
Last checked: Nov 19, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
36
Planned (sponsor's estimate)
Start
Aug 6, 2025
Primary completion
Jul 2028
Study completion Jul 2028
Sponsor
- Lead sponsor
- University of Colorado, DenverAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Ludeman Family Center for Women's Health Research
- First posted
- Jun 13, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- Female only, from 22 years, up to 40 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether NightWare therapeutic intervention improves biomarkers of vascular and renal function in premenopausal women with PTSD-related nightmares, and examine whether these improvements restore them to levels observed in age-matched women without PTSD.
Conditions
- Post Traumatic Stress Disorder
- Cardiovascular Diseases
- Autonomic Dysfunction
- Vascular Stiffness
- Nightmare
- Endothelial Dysfunction
- Kidney Diseases
- Renal Dysfunction
- Trauma and Stressor Related Disorders
Interventions
NightWareDevice
A wearable digital therapeutic platform consisting of an Apple Watch and iPhone pre-provisioned with Nightware intervention app that will deliver a mild vibration to the watch after detecting individual having a nightmare based on Nightware proprietary algorithm, arousing the individual and disrupting nightmare without awakening.
Sham NightWareDevice
NightWare decive will not deliver an intervention (i.e., no vibration)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Brachial artery flow-mediated dilation (FMD)Time frame: PTSD vs controls at baseline. In PTSD group only, change with NightWare vs Sham (measured pre and post-intervention 8 weeks of NightWare or sham conditions).
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
University of Colorado Anschutz Medical Campus
Aurora, Colorado · Recruiting
University of Colorado CCTSI CTRC
Denver, Colorado · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.